A systematic review of the pharmacological management of orthostatic hypotension

A C L Ong, P K Myint, L Shepstone, J F Potter

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objectives
The ‘short’ and ‘long-term’ benefits of pharmacological interventions to treat orthostatic hypotension (OH) remain unclear. The aim was to systematically examine the published literature on the effectiveness of different drug regimens for the treatment of OH.

Design
Systematic review.

Setting
MEDLINE (1950-Week 7, 2011), EMBASE (1980-Week 7, 2011), CINAHL (1981-Week 7, 2011) databases and hand-searching of bibliographies were used to identify suitable papers.

Participants
Studies selected were those, which investigated drug treatment of OH in a single- or double-blind randomised controlled trial (RCT) in humans over 18 years of age.

Measurements
Data were extracted from suitable full-text articles by three investigators independently.

Results
The 13 trials met the criteria for systematic review amongst which was considerable variation in the size of postural blood pressure (BP) change with active treatment. However, there was evidence that commonly used drugs midodrine or fludrocortisone therapy did increase standing or head-up-tilt (HUT) systolic blood pressure in certain patient groups.

Conclusion
The evidence that pharmacological therapy is of benefit for the treatment of OH is limited by the lack of good quality clinical trial evidence. Further well-designed RCTs of pharmacological treatment of OH investigating the impact on postural symptoms as well as actual BP changes are needed.
Original languageEnglish
Pages (from-to)633-646
Number of pages14
JournalInternational Journal of Clinical Practice
Volume67
Issue number7
Early online date13 Jun 2013
DOIs
Publication statusPublished - Jul 2013

Fingerprint

Orthostatic Hypotension
Pharmacology
Blood Pressure
Therapeutics
Midodrine
Fludrocortisone
Pharmaceutical Preparations
Bibliography
Randomized Controlled Trials
Head
Research Personnel
Clinical Trials
Databases

Keywords

  • Adult
  • Aged
  • Cardiovascular Agents
  • Double-Blind Method
  • Female
  • Fludrocortisone
  • Humans
  • Hypotension, Orthostatic
  • Male
  • Middle Aged
  • Midodrine
  • Octreotide
  • Pyridostigmine Bromide
  • Randomized Controlled Trials as Topic
  • Single-Blind Method
  • Treatment Outcome
  • Young Adult

Cite this

A systematic review of the pharmacological management of orthostatic hypotension. / Ong, A C L; Myint, P K; Shepstone, L; Potter, J F.

In: International Journal of Clinical Practice, Vol. 67, No. 7, 07.2013, p. 633-646.

Research output: Contribution to journalArticle

@article{52635d6a79aa4269b72c373926522b1c,
title = "A systematic review of the pharmacological management of orthostatic hypotension",
abstract = "ObjectivesThe ‘short’ and ‘long-term’ benefits of pharmacological interventions to treat orthostatic hypotension (OH) remain unclear. The aim was to systematically examine the published literature on the effectiveness of different drug regimens for the treatment of OH.DesignSystematic review.SettingMEDLINE (1950-Week 7, 2011), EMBASE (1980-Week 7, 2011), CINAHL (1981-Week 7, 2011) databases and hand-searching of bibliographies were used to identify suitable papers.ParticipantsStudies selected were those, which investigated drug treatment of OH in a single- or double-blind randomised controlled trial (RCT) in humans over 18 years of age.MeasurementsData were extracted from suitable full-text articles by three investigators independently.ResultsThe 13 trials met the criteria for systematic review amongst which was considerable variation in the size of postural blood pressure (BP) change with active treatment. However, there was evidence that commonly used drugs midodrine or fludrocortisone therapy did increase standing or head-up-tilt (HUT) systolic blood pressure in certain patient groups.ConclusionThe evidence that pharmacological therapy is of benefit for the treatment of OH is limited by the lack of good quality clinical trial evidence. Further well-designed RCTs of pharmacological treatment of OH investigating the impact on postural symptoms as well as actual BP changes are needed.",
keywords = "Adult, Aged, Cardiovascular Agents, Double-Blind Method, Female, Fludrocortisone, Humans, Hypotension, Orthostatic, Male, Middle Aged, Midodrine, Octreotide, Pyridostigmine Bromide, Randomized Controlled Trials as Topic, Single-Blind Method, Treatment Outcome, Young Adult",
author = "Ong, {A C L} and Myint, {P K} and L Shepstone and Potter, {J F}",
note = "{\circledC} 2013 John Wiley & Sons Ltd.",
year = "2013",
month = "7",
doi = "10.1111/ijcp.12122",
language = "English",
volume = "67",
pages = "633--646",
journal = "International Journal of Clinical Practice",
issn = "1368-5031",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - A systematic review of the pharmacological management of orthostatic hypotension

AU - Ong, A C L

AU - Myint, P K

AU - Shepstone, L

AU - Potter, J F

N1 - © 2013 John Wiley & Sons Ltd.

PY - 2013/7

Y1 - 2013/7

N2 - ObjectivesThe ‘short’ and ‘long-term’ benefits of pharmacological interventions to treat orthostatic hypotension (OH) remain unclear. The aim was to systematically examine the published literature on the effectiveness of different drug regimens for the treatment of OH.DesignSystematic review.SettingMEDLINE (1950-Week 7, 2011), EMBASE (1980-Week 7, 2011), CINAHL (1981-Week 7, 2011) databases and hand-searching of bibliographies were used to identify suitable papers.ParticipantsStudies selected were those, which investigated drug treatment of OH in a single- or double-blind randomised controlled trial (RCT) in humans over 18 years of age.MeasurementsData were extracted from suitable full-text articles by three investigators independently.ResultsThe 13 trials met the criteria for systematic review amongst which was considerable variation in the size of postural blood pressure (BP) change with active treatment. However, there was evidence that commonly used drugs midodrine or fludrocortisone therapy did increase standing or head-up-tilt (HUT) systolic blood pressure in certain patient groups.ConclusionThe evidence that pharmacological therapy is of benefit for the treatment of OH is limited by the lack of good quality clinical trial evidence. Further well-designed RCTs of pharmacological treatment of OH investigating the impact on postural symptoms as well as actual BP changes are needed.

AB - ObjectivesThe ‘short’ and ‘long-term’ benefits of pharmacological interventions to treat orthostatic hypotension (OH) remain unclear. The aim was to systematically examine the published literature on the effectiveness of different drug regimens for the treatment of OH.DesignSystematic review.SettingMEDLINE (1950-Week 7, 2011), EMBASE (1980-Week 7, 2011), CINAHL (1981-Week 7, 2011) databases and hand-searching of bibliographies were used to identify suitable papers.ParticipantsStudies selected were those, which investigated drug treatment of OH in a single- or double-blind randomised controlled trial (RCT) in humans over 18 years of age.MeasurementsData were extracted from suitable full-text articles by three investigators independently.ResultsThe 13 trials met the criteria for systematic review amongst which was considerable variation in the size of postural blood pressure (BP) change with active treatment. However, there was evidence that commonly used drugs midodrine or fludrocortisone therapy did increase standing or head-up-tilt (HUT) systolic blood pressure in certain patient groups.ConclusionThe evidence that pharmacological therapy is of benefit for the treatment of OH is limited by the lack of good quality clinical trial evidence. Further well-designed RCTs of pharmacological treatment of OH investigating the impact on postural symptoms as well as actual BP changes are needed.

KW - Adult

KW - Aged

KW - Cardiovascular Agents

KW - Double-Blind Method

KW - Female

KW - Fludrocortisone

KW - Humans

KW - Hypotension, Orthostatic

KW - Male

KW - Middle Aged

KW - Midodrine

KW - Octreotide

KW - Pyridostigmine Bromide

KW - Randomized Controlled Trials as Topic

KW - Single-Blind Method

KW - Treatment Outcome

KW - Young Adult

U2 - 10.1111/ijcp.12122

DO - 10.1111/ijcp.12122

M3 - Article

C2 - 23758443

VL - 67

SP - 633

EP - 646

JO - International Journal of Clinical Practice

JF - International Journal of Clinical Practice

SN - 1368-5031

IS - 7

ER -